ArticleACS medicinal chemistry letters2026

Novel 3‑Aza-Bicyclo[3.3.0]octane Compounds as ERK5 Inhibitors for Treating Cancer.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.